Ignite Creation Date:
2024-05-06 @ 8:27 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06386614
Status:
RECRUITING
Last Update Posted:
2024-05-21
First Post:
2024-04-23
Brief Title:
Effect of Frontal Transcranial Direct Current Stimulation on BDNF in Stroke Patients With Cognitive Impairment
Sponsor:
The Second Affiliated Hospital of Dalian Medical University
Organization:
The Second Affiliated Hospital of Dalian Medical University
Study Overview
Official Title:
The Second Hospital of Dalian Medical University
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the clinical trial is to find a treatment for stroke patients with cognitive impairment and the main questions it aims to answer are
Search for effective treatments of cognitive impairment after stroke
explore the relationship between BDNF level and cognitive function Participants will receive conventional treatment tDCS treatment And then compare cognitive function and BDNF level
Search for effective treatments of cognitive impairment after stroke
explore the relationship between BDNF level and cognitive function Participants will receive conventional treatment tDCS treatment And then compare cognitive function and BDNF level
Detailed Description:
1 To study the therapeutic effect of transcranial direct current stimulation tDCS on post-stroke cognitive impairment PSCI by evaluating cognitive function and detecting plasma brain-derived neurotrophic factor BDNF
2 To explore the correlation between plasma BDNF level and cognitive function in patients with PSCI
2 To explore the correlation between plasma BDNF level and cognitive function in patients with PSCI
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None